Decreased plasma levels of soluble receptor for advanced glycation end products in mild cognitive impairment

被引：0
|
作者：
R. Ghidoni
L. Benussi
M. Glionna
M. Franzoni
D. Geroldi
E. Emanuele
G. Binetti
机构：
[1] IRCCS “Centro S. Giovanni di Dio-FBF”,NeuroBioGen Lab
[2] AFaR,Memory Clinic
[3] University of Pavia,Interdepartmental Center for Research in Molecular Medicine (CIRMC)
来源：
Journal of Neural Transmission | 2008年 / 115卷
关键词：
Biological marker; Plasma; Mild cognitive impairment; sRAGE; AD; Cognitive decline;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Growing evidence advanced the idea that the soluble form of the receptor for advanced glycation end-products (sRAGE) might serve as a risk marker for several disorders including Alzheimer disease. We found a reduced level of circulating sRAGE in patients with mild cognitive impairment (MCI). The reduction of sRAGE in MCI, as well as the anticipation of the disease in patients with the lowest sRAGE levels (≤225 pg/ml), suggest a role of the RAGE axis in the pathogenesis of the disease.
引用
收藏
页码：1047 / 1050
页数：3
相关论文
共 50 条
  • [21] Decreased Soluble Receptor of Advanced Glycation End Product Levels Correlated with Inflammation in Silicosis
    Liu, Heliang
    Ma, Jingjing
    Jiang, Tian
    Li, Enhong
    Zhao, Xiaokun
    Wang, Ying
    Cui, Jie
    Hao, Xiaohui
    Guo, Lingli
    MEDIATORS OF INFLAMMATION, 2020, 2020
  • [22] CARDIOVASCULAR REMODELING IN MILD HYPERTENTION: ROLE OF SOLUBLE RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS
    Grossi, A.
    Corso, R.
    Tandurella, N.
    Moretti, S.
    Cavallaro, G.
    Test, L. Robustelli
    Agostinis, M.
    Pierobon, V.
    Tavecchia, L.
    Mancuso, V.
    Mongiardi, C.
    Montal-Betti, L.
    Guasti, L.
    Grandi, A. M.
    Maresca, A. M.
    JOURNAL OF HYPERTENSION, 2018, 36 : E230 - E231
  • [23] Positive association between serum levels of advanced glycation end products and the soluble form of receptor for advanced glycation end products in nondiabetic subjects
    Yamagishi, Sho-ichi
    Adachi, Hisashi
    Nakamura, Kazuo
    Matsui, Takanori
    Jinnouchi, Yuko
    Takenaka, Katsuhiko
    Takeuchi, Masayoshi
    Enomoto, Mika
    Furuki, Kumiko
    Hino, Asuka
    Shigeto, Yoshiyuki
    Imaizumi, Tsutomu
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2006, 55 (09): : 1227 - 1231
  • [24] Decreased plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus: association with oxidative stress and metabolic control
    Santilli, F.
    Devangelio, E.
    Formoso, G.
    Ferroni, P.
    Bucciarelli, L.
    Ciabattoni, G.
    Consoli, A.
    Davi, G.
    EUROPEAN HEART JOURNAL, 2006, 27 : 392 - 393
  • [25] Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes
    K. C. B. Tan
    S. W. M. Shiu
    W. S. Chow
    L. Leng
    R. Bucala
    D. J. Betteridge
    Diabetologia, 2006, 49 : 2756 - 2762
  • [26] Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes
    Tan, K. C. B.
    Shiu, S. W. M.
    Chow, W. S.
    Leng, L.
    Bucala, R.
    Betteridge, D. J.
    DIABETOLOGIA, 2006, 49 (11) : 2756 - 2762
  • [27] ADVANCED GLYCATION END PRODUCTS, SOLUBLE RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS AND RISK OF LIVER CANCER.
    Moy, K. A.
    Jiao, L.
    Freedman, N. D.
    Weinstein, S. J.
    Sinha, R.
    Virtamo, J.
    Albanes, D.
    Stolzenberg-Solomon, R. Z.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2012, 175 : S103 - S103
  • [28] Plasma advanced glycation end products and soluble receptor for advanced glycation end products as indicators of sterol content in human carotid atherosclerotic plaques
    Pinto, Raphael S.
    Ferreira, Guilherme S.
    Silvestre, Gina Camillo R.
    Santana, Monique de Fatima M.
    Nunes, Valeria S.
    Ledesma, Lucas
    Pinto, Paula R.
    de Assis, Sayonara Ivana S.
    Machado, Ubiratan F.
    da Silva, Erasmo S.
    Passarelli, Marisa
    DIABETES & VASCULAR DISEASE RESEARCH, 2022, 19 (01):
  • [29] Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control
    Pullerits, R
    Bokarewa, M
    Dahlberg, L
    Tarkowski, A
    ARTHRITIS RESEARCH & THERAPY, 2005, 7 (04) : R817 - R824
  • [30] Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control
    Rille Pullerits
    Maria Bokarewa
    Leif Dahlberg
    Andrej Tarkowski
    Arthritis Research & Therapy, 7
12345